Skip Navigation LinksNational Health Insurance Fund > News > One third of our citizens are taking reimbursable medicines
News
One third of our citizens are taking reimbursable medicines
2014-10-20

Out of all medicines necessary for the treatment and reimbursed from the budget of the Compulsory Health Insurance Fund, our citizens most often take drugs for cardiovascular, respiratory diseases and diabetes. The average price of such medicines used by one patient in the first half of this year was 329 Litas, in total 333 million Litas was spent for all prescribed reimbursable medicines and medical aids.

 

This was demonstrated in the analysis of the use of reimbursable medicines in Lithuania during the first half of the year carried out by the National Health Insurance Fund under the Ministry of Health (NHIF). Interestingly, that the users of these medicines were almost one third of citizens of Lithuania – 1.01 million of people covered by the compulsory health insurance (CHI).

 

Such tendencies indicate potential increase of annual expenses of the CHIF may up to 700 million Litas as well as number of people using medicines if consumption of reimbursable medicines further remains at the same level.

Based on the statement of Mrs. Kristina Garuolienė, Head of Department of Medicines Reimbursement of NHIF, analysis was carried out aiming to reveal regional disparities of medicines use, focusing on the medicines making the biggest part of all expenses.

 

 

Mrs. Kristina Garuolienė, Head of Department of Medicines Reimbursement of NHIF Photo of NHIF.

 

"Interesting differences were noticed in the analysis of average means required to treat one individual for a certain disease with reimbursable medicines in different regions. For example, 32.7 million Litas were spent for diabetes treatment during the first half of the year and almost 157 thousand patients were taking these medicines. This means, that on the average 208 Litas were spent for reimbursable medicines one patient with this disease. The expenses for anti-diabetic drugs for one patient living in Vilnius region were 186 Litas, and for one patient living in Kaunas region – 227 Litas", – said K. Garuolienė.

 

According to K, Garuolienė, there also are other regional differences. For example, 15 percent of all patients taking medicines in Klaipėda region take medicines for mental diseases (antipsychotics and sedatives), but in Vilnius such medicines have been prescribed for 12 percent patients only.

 

"Such differences between the regions could be explained partially by different accessibility of healthcare services, different social and demographic characteristics. Treatment methods applied by health care professionals also differ", – stated Mrs. K. Garuolienė.

 

NHIF Public Relations

Phone +370 5 236 4105, +370 5 237 0717, +370 5 236 4168

One third of our citizens are taking reimbursable medicines